Funingana, I.-G.; Piyatissa, P.; Reinius, M.; McCague, C.; Basu, B.; Sala, E.
Radiomic and Volumetric Measurements as Clinical Trial Endpoints—A Comprehensive Review. Cancers 2022, 14, 5076.
https://doi.org/10.3390/cancers14205076
AMA Style
Funingana I-G, Piyatissa P, Reinius M, McCague C, Basu B, Sala E.
Radiomic and Volumetric Measurements as Clinical Trial Endpoints—A Comprehensive Review. Cancers. 2022; 14(20):5076.
https://doi.org/10.3390/cancers14205076
Chicago/Turabian Style
Funingana, Ionut-Gabriel, Pubudu Piyatissa, Marika Reinius, Cathal McCague, Bristi Basu, and Evis Sala.
2022. "Radiomic and Volumetric Measurements as Clinical Trial Endpoints—A Comprehensive Review" Cancers 14, no. 20: 5076.
https://doi.org/10.3390/cancers14205076
APA Style
Funingana, I.-G., Piyatissa, P., Reinius, M., McCague, C., Basu, B., & Sala, E.
(2022). Radiomic and Volumetric Measurements as Clinical Trial Endpoints—A Comprehensive Review. Cancers, 14(20), 5076.
https://doi.org/10.3390/cancers14205076